Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by postie1on Jan 19, 2025 7:35pm
98 Views
Post# 36411257

RE:RE:RE:In a near future

RE:RE:RE:In a near futureJust my opinion  as once these products have gone through the trials anything less than $1.00 is not going to get most peoples' shares. There are a lot of small invettors in VM that own a big amount of shares. I personally think the PPs have been done in such a way as to prevent a lowball or sneaky accumalation of shares as when you look at the ask levels there is a big jump in price most days. To me that means most of us share holders are not traders and we want our just reward. And that is before the Iodine approvals and sales.
I am wondering when VM will either spin out  Jubilee and Pedley or give them up for a smelter royalty.Remember VM staked extra claims on trend at (I think) Jubilee because of historical drill values showing possibilities of base metals
 Anyway I am going to sit back and wait
<< Previous
Bullboard Posts
Next >>